Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan gets tentative approval for generic Depakote
Mylan has received the tentative approval for the drug in 250mg and 500mg strengths. Depakote ER is approved in the US for the treatment of bipolar disorder, epilepsy,
Mylan has received the tentative approval for the drug in 250mg and 500mg strengths. Depakote ER is approved in the US for the treatment of bipolar disorder, epilepsy,
In the study, the inhibitor produced a clinically and statistically significant reduction in the time to sustained relief for acute hereditary angioedema (HAE) symptoms. Based on the positive
The finding may help define the role of cancer stem cells in the growth and recurrence of the disease as well as offer new options for cancer prevention,
The decision will not affect Abbott drugs which are already on sale in Thailand. The military-backed government issued “compulsory licenses” in January allowing the generic manufacture of Abbott's
The trial is designed to assess the safety, tolerability and cognitive effects of three doses of MEM 3454 in subjects with mild to moderate Alzheimer's disease. The trial
Bristol-Myers Squibb plans to work with India's leading biotech firm Biocon Limited to further its research in medicinal chemistry, biology, drug metabolism, and pharmaceuticals. Under the terms of
The drug is the first targeted, once-daily oral treatment option for patients who have progressed beyond the standard treatment which includes anthracyclines, taxanes and Herceptin (trastuzumab). Tykerb inhibits
Roche told Californian biotech Maxygen that it was terminating the agreement based on the inability of the parties to establish an animal model intended to provide preclinical de-risking
Reuters said that the US drug regulator stood by the approvable letter that it sent Eli Lilly last September, which informed the drugmaker that a further study would
The alliance between the two companies was created to select specific proteins which can be manufactured into drugs that either have received orphan drug designation or have the